New recommendations on how to fix the issue of COVID misinformation don’t go far enough.
Academic rigour, journalistic flair
Articles on Coronavirus insights
Displaying 201 - 220 of 1079 articles
With pubs closed during lockdown, many British people opted to drink more at home.
Working from home resulted in a rebalancing of housework and childcare responsibilities – but not all couples were affected evenly.
Prioritising COVID patients who are vaccinated – or charging unvaccinated patients for treatment – isn’t the right thing to do.
Low faith in public figures and institutions may explain why uptake is lower in ethnic minority groups.
The new variant threatens to infect billions worldwide in early 2022.
Having a range of immune cells that target different parts of the virus appears to make disease milder and could protect against future variants.
Omicron is continuing the trend set by delta, causing symptoms that resemble the common cold.
Understanding the difference between COVID tests can help explain why the rules keep changing.
Here’s what we know so far.
The rule that antibiotics don’t work against viruses isn’t always true.
We overestimate how much we think others want the world to return to its pre-pandemic ways, which makes us pessimistic about the potential to make things better.
Revolutions in genome sequencing have been used to track COVID-19 in near real time.
A professor of digital society and an ethics researcher discuss COVID passes and what they mean for the UK.
The public has been asked to cut back on socialising ahead of Christmas – but does this request go far enough?
COVID passes lower the risk of transmission and incentivise vaccine uptake at a time when boosters are desperately needed.
Using trusted messengers, making sure that vaccine information is tailored to those being targeted, and greater flexibility over vaccination timing and venues could all increase uptake.
A third vaccine dose raises protection against omicron to 75%, early data suggests.
Antibodies in people’s blood seem much less able to neutralise the new variant – but these new findings should be treated with caution.
Sick pay is not available to everyone.
Top contributors
-
Senior Research Fellow in Global Health, University of Southampton
-
Associate Professor of Bioethics, University of Portsmouth
-
Professor of Medicine, University of East Anglia
-
Professor of Public Health, University of Sheffield
-
Lecturer in Psychology, Swansea University
-
Professor in Biomedical Sciences, University of Manchester
-
Professor of Mathematics and Statistics, University of Strathclyde
-
Associate Professor in Viral Immunology, University of Birmingham
-
Senior Lecturer in Mathematical Biology, University of Bath
-
Scientific Officer, University of Leeds
-
Principal Lecturer, Microbiology and Biomedical Science Practice, Fellow of the Institute of Biomedical Science, University of Brighton
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge
-
Assistant Professor in Health Promotion and Policy, UMass Amherst, UMass Amherst
-
Professor of Primary Care Health Sciences, University of Oxford
